Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding NP-GT8 and IL-12, With or Without a TLR-agonist-Adjuvanted HIV Env Trimer 4571 Boost, in Adults Without HIV
Clinical trial NCT05781542 · COMPLETED
Trial details
- NCT number
- NCT05781542
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-10
- Primary completion
- 2024-10-02
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.